Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
67.56
-1.22 (-1.77%)
At close: Sep 21, 2026, 4:00 PM EDT
67.56
0.00 (0.00%)
After-hours: Sep 21, 2026, 4:59 PM EDT
Cytokinetics Market Cap
Cytokinetics has a market cap or net worth of $9.39 billion as of September 21, 2026. Its market cap has increased by 61.31% in one year.
Market Cap
9.39B
Enterprise Value
9.65B
1-Year Change
61.31%
Ranking
Category
Stock Price
$67.56
ChartMarket Cap Chart
Since April 30, 2004, Cytokinetics's market cap has increased from $419.30M to $9.39B, an increase of 2,140.02%. That is a compound annual growth rate of 14.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 9.39B | 20.90% |
| Dec 31, 2025 | 7.77B | 39.94% |
| Dec 31, 2024 | 5.55B | -32.19% |
| Dec 29, 2023 | 8.19B | 88.80% |
| Dec 30, 2022 | 4.34B | 13.41% |
| Dec 31, 2021 | 3.82B | 159.95% |
| Dec 31, 2020 | 1.47B | 134.61% |
| Dec 31, 2019 | 626.90M | 81.29% |
| Dec 31, 2018 | 345.80M | -21.27% |
| Dec 29, 2017 | 439.20M | -10.79% |
| Dec 30, 2016 | 492.30M | 21.17% |
| Dec 31, 2015 | 406.30M | 38.57% |
| Dec 31, 2014 | 293.20M | 52.87% |
| Dec 31, 2013 | 191.80M | 104.04% |
| Dec 31, 2012 | 94.00M | 35.45% |
| Dec 30, 2011 | 69.40M | -49.60% |
| Dec 31, 2010 | 137.70M | -22.34% |
| Dec 31, 2009 | 177.30M | 25.83% |
| Dec 31, 2008 | 140.90M | -39.40% |
| Dec 31, 2007 | 232.50M | -17.84% |
| Dec 29, 2006 | 283.00M | 51.01% |
| Dec 30, 2005 | 187.40M | -35.49% |
| Dec 31, 2004 | 290.50M | -30.72% |
| Apr 30, 2004 | 419.30M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Axsome Therapeutics | 10.88B |
| Twist Bioscience | 10.47B |
| Krystal Biotech | 9.97B |
| Kymera Therapeutics | 9.79B |
| Arrowhead Pharmaceuticals | 9.39B |
| Protagonist Therapeutics | 9.25B |
| ABIVAX Société Anonyme | 9.10B |
| ImmunityBio | 8.99B |